Dynavax Technologies | Koszty Operacyjne



Operating Expenses Zmiana Data
AbbVie USD 9.71B 96M 2025-06
Adma Biologics USD 80.47M 268K 2024-12
Amgen USD 6.52B 337M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Biogen USD 1.79B 326.1M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Dynavax Technologies USD 81.01M 10.78M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Glaxosmithkline GBP 7.42B 408M 2024-12
Merck USD 9.44B 217M 2025-06
Neurocrine Biosciences USD 541.9M 7M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
TG Therapeutics USD 106.3M 5.93M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06


Dynavax Technologies Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.